Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$14.08 - $27.63 $1.73 Million - $3.4 Million
-123,100 Reduced 53.85%
105,500 $2.01 Million
Q4 2021

Feb 15, 2022

SELL
$26.55 - $40.57 $7.21 Million - $11 Million
-271,700 Reduced 54.31%
228,600 $6.07 Million
Q3 2021

Nov 16, 2021

BUY
$39.27 - $72.94 $8.39 Million - $15.6 Million
213,700 Added 74.56%
500,300 $20.6 Million
Q2 2021

Aug 16, 2021

SELL
$31.29 - $56.64 $359,835 - $651,360
-11,500 Reduced 3.86%
286,600 $16.2 Million
Q1 2021

May 18, 2021

BUY
$39.71 - $90.58 $2.86 Million - $6.52 Million
72,000 Added 31.84%
298,100 $12.5 Million
Q4 2020

Feb 17, 2021

BUY
$27.07 - $84.35 $4.52 Million - $14.1 Million
167,100 Added 283.22%
226,100 $15.9 Million
Q3 2020

Nov 17, 2020

BUY
$28.06 - $37.16 $507,886 - $672,595
18,100 Added 44.25%
59,000 $1.66 Million
Q2 2020

Aug 17, 2020

BUY
$18.5 - $34.34 $251,600 - $467,024
13,600 Added 49.82%
40,900 $1.21 Million
Q4 2019

Feb 14, 2020

BUY
$19.49 - $32.63 $187,103 - $313,248
9,600 Added 54.24%
27,300 $808,000
Q1 2018

May 15, 2018

BUY
$29.84 - $44.08 $528,168 - $780,216
17,700 New
17,700 $587,000
Q4 2017

Feb 15, 2018

SELL
$21.89 - $31.34 $391,831 - $560,986
-17,900 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$15.81 - $24.01 $282,999 - $429,779
17,900
17,900 $430,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $183M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.